• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.28% Nasdaq Up0.62%

    Perrigo Company Public Limited Company (PRGO)

    -NYSE
    165.54 Down 0.57(0.35%) 11:42AM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Perrigo Company Public Limited Company
    Treasury Building
    Lower Grand Canal Street
    Dublin, 2
    Ireland - Map
    Phone: 353 1 604 0031
    Website: http://www.perrigo.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Related Products
    Full Time Employees:10,220

    Business Summary 

    Perrigo Company plc, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, as well as in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services. The company’s Nutritionals segment offers infant and toddler formula products, infant and toddler foods, as well as vitamins, minerals, and dietary supplement products to retailers, distributors, and consumers. Its Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of Rx drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. This segment provides its products to chain drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. The company’s API segment develops, manufactures, and markets API that are used in the production of pharmaceutical products to generic drug industries and branded pharmaceutical companies. Its Specialty Sciences segment provides Tysabri, which is used for the treatment of Multiple Sclerosis; and Prialt, a non-narcotic intrathecal analgesic. The company also offers pharmaceutical and medical diagnostic products. The company offers its products primarily in the United States, the United Kingdom, Mexico, Israel, and Australia, as well as in Canada, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Perrigo Company Public Limited Company

    Corporate Governance 
    Perrigo Company Public Limited Company’s ISS Governance QuickScore as of Dec 1, 2014 is 4. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 2; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Joseph C. Papa , 58
    Chairman, Chief Exec. Officer and Pres
    13.24M6.95M
    Ms. Judy I. Brown , 46
    Chief Financial Officer and Exec. VP
    4.69M362.00K
    Mr. Todd W. Kingma , 54
    Exec. VP, Gen. Counsel and Sec.
    3.14M524.00K
    Mr. John T. Hendrickson , 51
    Exec. VP of Global Operations and Supply Chain
    2.04M554.00K
    Mr. Sharon Kochan , 46
    Exec. VP and Gen. Mang. of International
    2.00M82.00K
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders